Breaking News Instant updates and real-time market news.

TKPYY

Takeda Pharmaceutical Co. Ltd.

$23.61

0.3 (1.29%)

08:04
10/10/16
10/10
08:04
10/10/16
08:04

Takeda, Crescendo Biologics enter collaboration, license agreement

Crescendo Biologics and Takeda Pharmaceutical announced a global, strategic, multi-target collaboration and license agreement for the discovery, development and commercialization of Humabody -based therapeutics for cancer indications with a high unmet medical need. Crescendo will use its proprietary transgenic platform and engineering expertise to discover and optimally configure Humabody candidates against multiple targets selected by Takeda. Under the terms of the agreement, Crescendo is eligible to receive up to $36M, in a combination of an upfront payment, investment, research funding and preclinical milestones. Takeda will have the right to develop and commercialize Humabody-based therapeutics resulting from the collaboration. Crescendo is also eligible to receive further clinical development, regulatory and sales-based milestone payments of up to $754M. In addition, Crescendo will be eligible to receive royalties on Humabody-based product sales by Takeda. Takeda signed agreements with Crescendo Biologics through its wholly-owned subsidiary, Millennium Pharmaceuticals, Inc.

TKPYY Takeda Pharmaceutical Co. Ltd.
$23.61

0.3 (1.29%)

06/08/16
RHCO
06/08/16
NO CHANGE
RHCO
Ultragenyx collaboration with Takeda 'exceptionally positive,' says SunTrust
After Ultragenyx (RARE) announced a development and commercialization collaboration for rare genetic diseases with Takeda (TKPYY), SunTrust says the deal terms are "exceptionally positive" for Ultragenyx. The firm notes that the latter company will receive both compounds and cash payments from Takeda, while Takeda will only get comemrcial rights in Asia. The firm keeps a Buy rating on Ultragenyx.
07/07/16
UBSW
07/07/16
INITIATION
UBSW
Neutral
Takeda Pharmaceutical initiated with a Neutral at UBS
UBS analyst Atsushi Seki started Takeda with a Neutral rating and Y4,600 price target.
09/14/16
SBSH
09/14/16
NO CHANGE
Target $4
SBSH
Neutral
Citi views Synergy Pharmaceuticals as potential target for Takeda
Citi analyst Liav Abraham calls Synergy Pharmaceuticals (SGYP) the most likely potential target for Takeda Pharmaceutical (TKPYY) among her coverage universe. The Financial Times earlier today reported that Takeda is ready to spend as much as $15B in acquisitions to expand its business in the United States. Abraham has a Neutral rating on Synergy with a $4 price target. The analyst sees Synergy as a potential target given the "extensive resources" needed to commercialize its lead asset, plecanatide, as well as Takdea's presence in the irritable bowel syndrome/chronic idiopathic constipation space. Shares of Synergy are up 6% to $5.18 in early trading.
09/15/16
WELS
09/15/16
NO CHANGE
WELS
Street underestimating potential of PRA Health deal, says Wells Fargo
Wells Fargo believes that the Street is underestimating the potential benefit to PRA Health (PRAH) of its deal with Takeda (TKPYY). The firm expects PRA's bookings over the next year to significantly exceed the industry average, causing 2017 and 2018 consensus estimates for the company to rise. Wells raised its price target on PRA to $65-$67 from $56-$59 and keeps an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

TXN

Texas Instruments

$82.37

1.29 (1.59%)

16:34
04/25/17
04/25
16:34
04/25/17
16:34
Hot Stocks
Texas Instruments reports inventory at end of Q1 at 132 days »

Management said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 09

    May

  • 31

    May

EQR

Equity Residential

$64.93

0.73 (1.14%)

16:34
04/25/17
04/25
16:34
04/25/17
16:34
Earnings
Equity Residential sees Q2 normalized FFO 75c-79c »

Sees Q2 EPS 51c-55c, may…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 15

    Jun

JNPR

Juniper

$27.78

-0.49 (-1.73%)

16:33
04/25/17
04/25
16:33
04/25/17
16:33
Technical Analysis
Juniper nears 52-week high after results »

Shares were last up over…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 25

    May

  • 08

    Jun

EQR

Equity Residential

$64.93

0.73 (1.14%)

16:33
04/25/17
04/25
16:33
04/25/17
16:33
Earnings
Equity Residential reports Q1 normalized FFO 74c vs. 76c last year »

Reports Q1 EPS 39c,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 15

    Jun

TXN

Texas Instruments

$82.37

1.29 (1.59%)

16:33
04/25/17
04/25
16:33
04/25/17
16:33
Hot Stocks
Texas Instruments reports cash flow from operations $4.8B for trailing 12 months »

Management said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 09

    May

  • 31

    May

PEI

Pennsylvania REIT

$14.59

-0.01 (-0.07%)

16:33
04/25/17
04/25
16:33
04/25/17
16:33
Hot Stocks
Pennsylvania REIT reports Q1 same Store NOI was flat compared to prior year »

Reports Q1 same Store NOI…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

OKSB

Southwest Bancorp

$25.75

0.2 (0.78%)

16:33
04/25/17
04/25
16:33
04/25/17
16:33
Earnings
Breaking Earnings news story on Southwest Bancorp »

Southwest Bancorp reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 26

    Apr

PEI

Pennsylvania REIT

$14.59

-0.01 (-0.07%)

16:33
04/25/17
04/25
16:33
04/25/17
16:33
Earnings
Pennsylvania REIT reports Q1 EPS (10c), consensus (8c) »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

CLGX

CoreLogic

$41.96

-0.14 (-0.33%)

16:32
04/25/17
04/25
16:32
04/25/17
16:32
Earnings
CoreLogic reports Q1 adjusted EPS 37c, consensus 39c »

Reports Q1 revenue $440M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

TXN

Texas Instruments

$82.37

1.29 (1.59%)

16:32
04/25/17
04/25
16:32
04/25/17
16:32
Hot Stocks
Breaking Hot Stocks news story on Texas Instruments »

Texas Instruments reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 09

    May

  • 31

    May

TXN

Texas Instruments

$82.37

1.29 (1.59%)

16:32
04/25/17
04/25
16:32
04/25/17
16:32
Earnings
Texas Instruments sees Q2 EPS 89c-$1.01, consensus 91c »

Sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 09

    May

  • 31

    May

JNS

Janus Capital

$13.45

0.02 (0.15%)

16:32
04/25/17
04/25
16:32
04/25/17
16:32
Hot Stocks
Janus Capital shareholders approve merger with Henderson Group »

Janus Capital Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

TRMK

Trustmark

$32.97

0.14 (0.43%)

16:31
04/25/17
04/25
16:31
04/25/17
16:31
Earnings
Trustmark reports Q1 EPS 46c, consensus 41c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 26

    Apr

X

U.S. Steel

$31.11

-0.09 (-0.29%)

16:31
04/25/17
04/25
16:31
04/25/17
16:31
Hot Stocks
U.S. Steel drops over 15% in after-hours following earnings report »

U.S. Steel shares are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

16:31
04/25/17
04/25
16:31
04/25/17
16:31
Options
Preliminary option volume of 19.4M today »

Preliminary option volume…

TXN

Texas Instruments

$82.37

1.29 (1.59%)

16:30
04/25/17
04/25
16:30
04/25/17
16:30
Earnings
Texas Instruments reports Q1 EPS 97c, consensus 83c »

Reports Q1 revenue $3.4B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 09

    May

  • 31

    May

CHSP

Chesapeake Lodging

$24.70

0.29 (1.19%)

16:29
04/25/17
04/25
16:29
04/25/17
16:29
Earnings
Chesapeake Lodging sees Q2 AFFO 60c-64c »

Sees Q2 EPS 27c-30c,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 17

    May

TGI

Triumph Group

$26.20

-0.05 (-0.19%)

16:29
04/25/17
04/25
16:29
04/25/17
16:29
Hot Stocks
Triumph Group, VAS Aero collaborate on PW4168 Nacelles »

Triumph Group said it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNPR

Juniper

$27.78

-0.49 (-1.73%)

16:28
04/25/17
04/25
16:28
04/25/17
16:28
Earnings
Juniper reports preliminary Q1 EPS 46c, consensus 42c »

Reports preliminary Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 25

    May

  • 08

    Jun

CHSP

Chesapeake Lodging

$24.70

0.29 (1.19%)

16:28
04/25/17
04/25
16:28
04/25/17
16:28
Earnings
Chesapeake Lodging backs FY17 adjusted FFO $2.10-$2.20 »

Backs FY17 EPS 73c-83c,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 17

    May

ARCW

ARC Group

$3.85

0.05 (1.32%)

16:28
04/25/17
04/25
16:28
04/25/17
16:28
Hot Stocks
Breaking Hot Stocks news story on ARC Group »

Northern Right Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHSP

Chesapeake Lodging

$24.70

0.29 (1.19%)

16:27
04/25/17
04/25
16:27
04/25/17
16:27
Earnings
Chesapeake Lodging reports Q1 adjusted FFO 41c »

Reports Q1 EPS 9c,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 17

    May

BXMT

Blackstone Mortgage

$30.91

0.28 (0.91%)

16:26
04/25/17
04/25
16:26
04/25/17
16:26
Earnings
Blackstone Mortgage reports Q1 core EPS 61c, consensus 63c »

Reports book value of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CCUR

Concurrent

$4.94

0.0626 (1.28%)

16:26
04/25/17
04/25
16:26
04/25/17
16:26
Hot Stocks
Concurrent announces availability of Origin Release 3 »

Concurrent announces the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UHS

Universal Health

$121.42

0.52 (0.43%)

16:25
04/25/17
04/25
16:25
04/25/17
16:25
Earnings
Universal Health reports Q1 adjusted EPS $2.10, consensus $2.07 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 03

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.